Втулка из карбида вольфрама

Posted on by

Втулка из карбида вольфрама

Втулка из карбида вольфрама является основным материалом среди фрикционных материалов. Рукава широко используются во многих отраслях промышленности. Втулка из карбида вольфрама может выдерживать высокое давление и устойчива к коррозии, поэтому используется в водяных насосах, масляных насосах и различных других насосах.
Втулка из карбида вольфрама является основным материалом среди фрикционных материалов. Рукава широко используются во многих отраслях промышленности. Втулка из карбида вольфрама может выдерживать высокое давление и устойчива к коррозии, поэтому используется в водяных насосах, масляных насосах и различных других насосах. Сегодня втулка из карбида вольфрама играет значительную роль в производстве материалов для длинных рабочих деталей.
Преимущество рукавов из карбида вольфрама
Мы являемся специализированным производителем втулки вала из карбида вольфрама, с лучшими производственными возможностями, лучшим контролем качества, лучшим сервисом и конкурентоспособной ценой;
100% чистое сырье из карбида вольфрама;
Спекание HIP, хорошая компактность;
Превосходная производительность и хорошая устойчивость к износу и коррозии
Гарантия высокой точности и хорошего качества. 100% контроль качества перед отправкой;
Чрезвычайно хорошее зеркальное покрытие поверхности плюс блестящие характеристики продукта;
С современным оборудованием;
Умеренная цена, оптимальные сроки доставки;
Форма, размер, материал и т. Д. Изготавливаются в соответствии с требованиями клиентов.

Все износостойкие карбидные износостойкие детали изготовлены ООО WEISON Передовые материалы, что обеспечивает превосходную износостойкость.
https://www.weisontungsten.com/product/tungsten-carbide-sleeves-in-the-oil-industry

Втулка из карбида вольфрама

Smelly Diapers Help McIlroy Forget About Stinky Results

SPORTS

CHANGE LANGUAGE
English
हिन्दी বাংলা मराठी ગુજરાતી ಕನ್ನಡ தமிழ் മലയാളം తెలుగు ਪੰਜਾਬੀ اردو অসমীয়া ଓଡ଼ିଆ
WATCH LIVE TV
DOWNLOAD News18 APP
Follow Us On
Trending Topics : #GaneshChaturthi#CricketCoronavirus#CovidData
News18 »
1-MIN READ

Smelly Diapers Help McIlroy Forget About Stinky Results

Smelly Diapers Help McIlroy Forget About Stinky Results

Playing his first major as a dad, Rory McIlroy brings a new perspective with him to this week's U.S. Open, the Northern Irishman saying on Tuesday that smelly diapers now require more immediate attention than stinky results.

  • Last Updated: September 16, 2020, 7:27 AM IST

Playing his first major as a dad, Rory McIlroy brings a new perspective with him to this week’s U.S. Open, the Northern Irishman saying on Tuesday that smelly diapers now require more immediate attention than stinky results.

“I actually changed the first two diapers, so I’m very proud of that,” said McIlroy, sounding as if he had just aced the par three seventh at Winged Foot Golf Club, the site of this year’s U.S. Open. “I’ve got my hands dirty; put it that way.”

Diaper duty is just one of the new skills McIlroy has had to work on since the August arrival of his daughter Poppy, who has brought perspective to someone once consumed with winning trophies.

A four-time major winner, McIlroy has not won one of golf’s big prizes since the 2014 PGA Championship and is without a tournament win of any sort since the World Golf Championship HSBC Champions last November.

Even though McIlroy is a former U.S. Open winner, that victory was in 2011 and in the last four years he has missed the cut three times.

It was those disappointing performances that McIlroy carried around with him long after the tournament was over but now, coming home to a daughter’s smile, he is learning there is more to life than birdies and bogeys.

“I think it just puts things in perspective a little bit,” said McIlroy, about having a child. “It makes the hard days a little easier to get over, right.

“And I’m not saying that I want to have hard days to get over, but you’re a little more relaxed.

“When I say it’s not the be-all and end-all, it’s a major championship and I’ve grown up my whole life dreaming of winning these tournaments, and that’s not going to change.

“But if it doesn’t quite happen, I can live with that and go home and be very happy and leave what’s happened at the golf course at the golf course.

“I think maybe something that I haven’t done so well in the past is I haven’t left my job at the office basically, I’ve brought it home with me, and I’ve let it affect my mood and how I am.”

Next Story
Loading

Втулка из карбида вольфрама

Serum Institute Of India Gets Nods To Resume Clinical Trial Of Oxford COVID-19 Vaccine
September 16, 2020
Corona
Home  »  Website  »  National  »  Serum Institute Of India Gets Nods To Resume Clinical Trial Of Oxford COVID-19 Vaccine

Serum Institute Of India Gets Nods To Resume Clinical Trial Of Oxford COVID-19 Vaccine

The Drugs Controller General of India (DCGI) Dr V G Somani had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford COVID-19 vaccine candidate till further orders.

PTI 16 September 2020
Google + Linkedin Whatsapp
Follow Outlook India On News
Serum Institute Of India Gets Nods To Resume Clinical Trial Of Oxford COVID-19 Vaccine
Representational image.
AP
Serum Institute Of India Gets Nods To Resume Clinical Trial Of Oxford COVID-19 Vaccine
outlookindia.com
2020-09-16T08:19:22+05:30
Also read

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.

The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be "scrupulously" followed by Serum Institute of India (SII).

SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

The DCGI had on September 11 directed Serum Institute of India to suspend any new recruitment in the phase two and three clinical trial of the Oxford COVID-19 vaccine candidate till further orders in the backdrop of pharma giant AstraZeneca pausing the clinical trials in other countries because of ''an unexplained illness'' in a participant in the study.

On Saturday, British-Swedish biopharmaceutical giant AstraZeneca and the University of Oxford said clinical trials for their coronavirus vaccine have resumed in the UK after the Medicines Health Regulatory Authority's (MHRA) confirmed that the trials were safe.

SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for COVID-19, on Tuesday submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial.

According to Tuesday's order issued by DCGI, the DSMB, UK, recommended that the investigators recommence all immunization in their clinical trials subject to certain conditions.

DSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain conditions.

According to the order, SII has submitted revised participant information sheet, revised informed consent form and additional safety monitoring plan for the evolved participants.

The Pune-based firm has also submitted a summary of safety follow up of seven days post first vaccination, stating that no serious adverse events were experienced by any of the subjects till the date of the reporting, and the reported adverse events were stated to be mild, resolved on their own and did not have any sequale.

"In view of the above, I Dr V G Somani, Drugs Controller General of India, Central Licensing Authority, after careful examination of your reply and the recommendations of the DSMB in India and in UK revoke herewith the order dated September 11 issued under Rule 30 of the New Drugs and Clinical Trials Rules, 2019.

"You may recommence the clinical trial as recommended by DSMB, India, as per already approved protocol and the provisions laid down under the New Drugs and Clinical Trial Rules, 2019, subject to the conditions mentioned," the order said.

For in-depth, objective and more importantly balanced journalism, Click here to subscribe to Outlook Magazine
Next Story >>

J-K: Army Officer Among 3 Personnel Injured In Pakistan Firing Along LoC

Google + Linkedin Whatsapp

Read More in:

PTI New Delhi COVID-19 Vaccine National

More from India

More From Outlook Magazine

More from Website

More from Blog

The Latest Issue

Outlook Videos

×

Втулка из карбида вольфрама

Spurs In Talks With Real Madrid To Re-sign Bale, Says Agent

SPORTS

CHANGE LANGUAGE
English
हिन्दी বাংলা मराठी ગુજરાતી ಕನ್ನಡ தமிழ் മലയാളം తెలుగు ਪੰਜਾਬੀ اردو অসমীয়া ଓଡ଼ିଆ
WATCH LIVE TV
DOWNLOAD News18 APP
Follow Us On
Trending Topics : #GaneshChaturthi#CricketCoronavirus#CovidData
News18 »
1-MIN READ

Spurs In Talks With Real Madrid To Re-sign Bale, Says Agent

Spurs In Talks With Real Madrid To Re-sign Bale, Says Agent

Tottenham Hotspur are in talks with Real Madrid to resign winger Gareth Bale, his agent said on Tuesday, as the Wales international looks to end his troubled spell at the Spanish club.

  • Last Updated: September 16, 2020, 7:24 AM IST

Tottenham Hotspur are in talks with Real Madrid to re-sign winger Gareth Bale, his agent said on Tuesday, as the Wales international looks to end his troubled spell at the Spanish club.

Bale made over 200 appearances for Premier League Spurs between 2007 and 2013, scoring 56 goals with 58 assists before his then world record move to Real for 100 million euros ($118.46 million).

The 31-year-old has scored over 100 goals for the Madrid side and won numerous trophies, including four Champions League titles, but was give limited playing time under Zinedine Zidane towards the end of last season’s La Liga triumph.

“Gareth still loves Spurs,” his agent Jonathan Barnett told the BBC on Tuesday. “We are talking (Spurs, Real and Bale’s camp). It’s where he wants to be.”

Bale endured his worst season at the Spanish club in 2019-20 with only three goals in all competitions and admitted earlier this month that he would consider a return to the Premier League if Real allow him to end his stint in Spain.

The Welshman has a contract until 2022 and was set to make a lucrative move to the Chinese Super League last year before the transfer was scuttled when Real made a last-minute decision to insist on a transfer fee rather than terminate his contract.

Bale has since divided opinion among the club’s fanbase, with some supporters frustrated by a perceived lack of commitment from the Welshman.

He did not feature in their final seven league matches as they pipped Barcelona to the Liga title while he watched on from the bench.

($1 = 0.8442 euros)

Next Story
Loading